<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">DVTs</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="2984" role="article" about="/commodorecompendium/dvts" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><div class="WordSection1">
<div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Deep Vein Thromboses – Trey Richardson</span></span></b></span></span></span></span></p>
</div>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Background: </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">Incidence of 1-2 per 1,000 people per year</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Depending on the study and population, associated with a 15% mortality rate </span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">70% of patients with PE have a detectable DVT</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">List of deep veins</span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Distal Lower Ext.: Posterior tibial, Anterior tibial, Peroneal, Gastrocnemius, Soleus veins </span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Proximal Lower Ext.: External, Internal, and Common iliac; Common, superficial, and deep femoral veins; Popliteal vein </span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Upper extremity: Radial, ulnar, brachial, axillary, and subclavian veins </span></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Risk Factors for Provoked DVT/PE – Known Event</span></span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Major risk factors: major surgery &gt;30 minutes, hospitalization &gt; 3 days, C-section</span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Minor Risk Factors: Surgery &lt;30 minutes, Hospitalization &lt;3 days, pregnancy, estrogen therapy, reduced mobility &gt;3 days, infection in past 3 months </span></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Persistent risk factors: Malignancy (active), inflammatory bowel disease, hereditary thrombophilia, CHF</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Active cancer (LR of 2.6) recent trauma/surgery or immobilization (LR of 1.6 each) are the clinical scenarios when suspicion should be the highest</span></span></span></span></span></span></li>
</ul>
</div>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Presentation</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Asymmetric calf swelling of &gt; 2cm sensitivity/specificity for DVT of 60-70% and a likelihood ratio (LR) of 2.1 </span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Evaluation</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Wells’ Criteria for DVT can help guide diagnostic testing</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">If a patient has a low pre-test probability, a negative D-dimer can rule out DVT</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">In a high pre-test probability patient a negative D-dimer is less helpful</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Whole-leg (common femoral to deep calf veins) ultrasounds with doppler</span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Prophylaxis </span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Padua score: Score &gt; 4 high risk; A score &lt;4 low risk for thrombosis</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Choice of anticoagulation for treatment: (See anticoagulation section)</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Duration of treatment</span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Provoked: 3-6 mos or until provoking factor (trauma, surgery, malignancy) is removed </span></span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Pts w/high risk cancers require more tailored therapy since the provoking factor is the malignancy itself. GI malignancies tend to be the highest risk. </span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Unprovoked: Requires life-long anticoagulation along with assistance from hematology</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Recurrent: Even if they have all ben provoked, requires life-long treatment </span></span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Close follow-up with hematology</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Distal:  Limited data, but can treat for 3 months or monitor for resolution with serial US </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Upper Extremity: Treat as DVT for at least 3 months </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Superficial vein : treat for 3 mo, if within 2 cm of junction w/ deep vein (high risk of propagation)</span></span></span></span></span></span></li>
</ul>
</li>
</ul>
<p style="margin-left:24px"> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Additional Information</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Decision to screen for hyper-coagulable disorders based on age (&lt;45), history of prior DVTs, family hx of clotting disorders, and hx of thrombi in atypical locations (arterial)  </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">If no contraindications (acute bleeding, planned procedure, thrombocytopenia etc.) then most patients will tolerate prophylaxis</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Follow up ultrasound </span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Limited data regarding utility of follow up ultrasound but may be warranted if patient at high risk for post-thrombotic complications or has persistent symptoms</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">What about IVC filters?</span></span></span></span></span></span>
<ul>
<li><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">In patients at high risk for DVT and in whom anti-coagulation is contraindicated (thrombocytopenia, recent intra-cranial bleed, recent GI bleed) placement of a retrievable IVC filter should be discussed with IR</span></span></span></li>
</ul>
</li>
</ul>
</div>
</div>
</article>
</div>
</div>